PCP
LUMO

Proficio Capital Partners’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Proficio Capital Partners’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-446
Closed -$6K – 1629
2019
Q2 		$6K Hold
446
– – ﹤0.01% 1168
2019
Q1 		$8K Buy
+446
New +$6.65K ﹤0.01% 974

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Proficio Capital Partners's LUMO Position: Q3 2019 in Review

Proficio Capital Partners sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2019, closing a stake of 446 shares — an estimated $6K sold.

Proficio Capital Partners first reported a position in LUMO in Q1 2019 and held it in 2 quarters. The position peaked at $8K in Q1 2019. 68 funds tracked by Wall St. Rank hold LUMO as of Q3 2019.

  • Proficio Capital Partners reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 446 Lumos Pharma, Inc. Common Stock shares in Q3 2019, an estimated $6K.
  • Proficio Capital Partners first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Proficio Capital Partners's Lumos Pharma, Inc. Common Stock position peaked at $8K in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.